Daniel Vasella, CEO Novartis speaks to Joerg Reinhardt, Chief Operating Officer

Daniel Vasella, CEO Novartis speaks to Joerg Reinhardt, Chief Operating Officer
epa01616429 Daniel Vasella, CEO Novartis (R), speaks to Joerg Reinhardt, Chief Operating Officer (L), during the full-year results 2008 press conference in Basel, Switzerland, 28 January 2009. Swiss pharmaceutical giant Novartis reported 28 January a 25 percent jump in profits in 2008 to 8.16 billion dollars (6.2 billion euros) and forecast a record year in 2009. Boosted by vaccines, diagnostics and consumer health products, the company said sales increased by nine percent to 41.6 billion dollars in 2008. EPA/PATRICK STRAUB